Z226173

Colonne HPLC Nucléosil^®

5 μm particle size, L × I.D. 15 cm × 4.6 mm

• Code UNSPSC : 41115700
• eCl@ss : 32110501
• Nomenclature NACRES : SB.52

Propriétés

• Agence: suitable for USP L1
• Niveau de qualité: 100
• Gamme de produits: Nucleosil^®
• Caractéristiques: endcapped
• Fabricant/nom de marque: Nucleosil^®
• Ampleur du marquage: 15% Carbon loading
• Paramètres: ≤70 °C temp. range; 400 bar pressure (5801 psi)
• Technique(s): HPLC: suitable
• L × D.I.: 15 cm × 4.6 mm
• Superficie: 350 m²/g
• Matrice: octadecyl
• Groupe de la matrice active: C18 (octadecyl) phase
• Taille des particules: 5 μm
• Dimension de pores: 100 Å
• Technique de séparation: reversed phase

Description

Application

• Quantification and Validation of Stability-Indicating RP-HPLC Method for Efavirenz: Demonstrates the utility of Nucleosil^® C18 HPLC Column in pharmaceutical analysis, particularly in quality control and stability testing of Efavirenz, ensuring compliance with regulatory standards (Gurumukhi VC, Bari SB, 2022).


• Development of new method for simultaneous analysis of piracetam and levetiracetam: This study uses the Nucleosil^® C18 column to develop robust methods for analyzing neurological medications in pharmaceuticals and biological fluids, contributing to drug stability studies (Siddiqui FA et al., 2014).


• HPLC method for determination of biologically active epoxy-transformers of treosulfan: The column′s application in plasma analysis highlights its role in pharmacokinetic studies, offering precise measurements critical for dosing and therapeutic monitoring (Główka FK et al., 2012).


• HPLC analysis of mitoxantrone in mouse plasma and tissues: Illustrates the column′s effectiveness in a pharmacokinetic study, underscoring its importance in the preclinical evaluation of cancer therapies (An G, Morris ME, 2010).


• Development and validation of an HPLC method for vancomycin: This application in a pharmacokinetic study highlights the column′s critical role in the development and validation of methods for antibiotic analysis, ensuring therapeutic efficacy and safety (Jesús Valle MJ et al., 2008).

Produits recommandés

Discover LiChropur reagents ideal for HPLC or LC-MS analysis

Informations légales

Nucleosil is a registered trademark of Macherey-Nagel GmbH & Co. KG